Glycerin suppositories are a novel way to relieve discomfort in both adults and children. They are small, easy-to-use rectal inserts that can provide relief from constipation, abdominal pain, and other digestive issues. Glycerin suppositories are safe and effective, and have a low risk of side effects. In this article, we will discuss what glycerin suppositories are, how they work, and when they should be used.
Glycerin suppositories are small, oval-shaped rectal inserts that contain glycerin, a sugar alcohol. Glycerin is a colorless, odorless, and non-toxic substance that acts as a lubricant and softens stool. Glycerin suppositories come in different sizes and shapes, and are available over-the-counter or by prescription.
Glycerin suppositories work by increasing the amount of water and lubrication in the rectum. This helps soften stool, making it easier to pass. The glycerin also acts as a stimulant, increasing the contraction of the rectal muscles and causing the body to expel stool.
Glycerin suppositories can be used to relieve constipation, abdominal pain, and other digestive issues. They are particularly effective for relieving constipation in children. Glycerin suppositories can also be used to treat fecal impaction, a condition in which stool becomes impacted in the rectum and is difficult to pass.
Glycerin suppositories are generally safe and have a low risk of side effects. They should not be used by people who are allergic to glycerin or other ingredients in the suppositories. It is also important to follow the directions on the package carefully.
Glycerin suppositories are a safe and effective way to relieve discomfort from constipation, abdominal pain, and other digestive issues. They are easy to use and have a low risk of side effects. It is important to follow the directions on the package carefully and to talk to a doctor if you have any questions or concerns.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation